摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-乙酰-DL-4-氟苯基苯胺 | 17481-06-0

中文名称
N-乙酰-DL-4-氟苯基苯胺
中文别名
N-乙酰基-4-氟-DL-苯丙氨酸;N-乙酰-DL-4-氟苯丙氨酸;N-乙酰-DL-4-氟苯基丙氨酸
英文名称
rac-Ac-p-F-Phe-OH
英文别名
N-acetyl-p-fluoro-dl-phenylalanine;N-acetyl-4-fluoro-DL-phenylalanine;N-Acetyl-4-fluor-DL-phenylalanin;N-acetyl-4-fluoro-3-phenyl-DL-alanine;2-acetamido-3-(4-fluorophenyl)propanoic acid
N-乙酰-DL-4-氟苯基苯胺化学式
CAS
17481-06-0
化学式
C11H12FNO3
mdl
——
分子量
225.22
InChiKey
NRLBRFQYMSTLJK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    150-153 °C(lit.)
  • 沸点:
    458.9±40.0 °C(Predicted)
  • 密度:
    1.2317 (estimate)
  • 稳定性/保质期:
    常温常压下稳定,避免与氧化物接触。

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    66.4
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • TSCA:
    Yes
  • 危险品标志:
    Xi
  • WGK Germany:
    3
  • 海关编码:
    2924299090
  • 安全说明:
    S24/25
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:ed471faa952694bcbe147d7d0cbea547
查看
Name: n- Acetyl-4-Fluoro-DL-Phenylalanine 98% Material Safety Data Sheet
Synonym: Non
CAS: 17481-06-0
Section 1 - Chemical Product MSDS Name:n- Acetyl-4-Fluoro-DL-Phenylalanine 98% Material Safety Data Sheet
Synonym:Non

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
17481-06-0 N-Acetyl-4-fluoro-DL-phenylalanine 98% 241-495-5
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use water fog, dry chemical, carbon dioxide, or regular foam. Use agent most appropriate to extinguish fire.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Exposure Limits CAS# 17481-06-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystals
Color: colorless, white semi-transparent
Odor: aromatic odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 150 - 153 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C11H12FNO3
Molecular Weight: 225.22

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures. Has not been fully evaluated.
Conditions to Avoid:
Incompatible materials, none reported, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing materials.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 17481-06-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-Acetyl-4-fluoro-DL-phenylalanine - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 17481-06-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 17481-06-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 17481-06-0 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    The Synthesis of 2-Fluoro-DL-tyrosine and 2-Fluoro-4-methoxy-DL-phenylalanine
    摘要:
    DOI:
    10.1021/ja01160a113
  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 sodium hydroxide 作用下, 生成 N-乙酰-DL-4-氟苯基苯胺
    参考文献:
    名称:
    The Synthesis of 2-Fluoro-DL-tyrosine and 2-Fluoro-4-methoxy-DL-phenylalanine
    摘要:
    DOI:
    10.1021/ja01160a113
点击查看最新优质反应信息

文献信息

  • [EN] GRANZYME B DIRECTED IMAGING AND THERAPY<br/>[FR] IMAGERIE DU GRANZYME B ET THÉRAPIE DIRIGÉES CONTRE LE GRANZYME B
    申请人:CYTOSITE BIOPHARMA INC
    公开号:WO2019160916A1
    公开(公告)日:2019-08-22
    Provided herein are heterocyclic compounds useful for imaging Granzyme B. Methods of imaging Granzyme B, combination therapies, and kits comprising the Granzyme B imaging agents are also provided.
    本文提供了用于成像Granzyme B的杂环化合物。还提供了成像Granzyme B的方法、联合疗法以及包含Granzyme B成像试剂的试剂盒。
  • Minisci‐Type Alkylation of <i>N</i> ‐Heteroarenes by <i>N</i> ‐(Acyloxy)phthalimide Esters Mediated by a Hantzsch Ester And Blue LED Light
    作者:Jiacheng Li、Suan Siang Tan、Sara Helen Kyne、Philip Wai Hong Chan
    DOI:10.1002/adsc.202101195
    日期:2022.2.15
    A synthetic method that enables the Hantzsch ester-mediated Minisci-type C2-alkylation of quinolines, isoquinolines and pyridines by N-(acyloxy)phthalimide esters (NHPI) under blue LED (light emitting diode) light (456 nm) is described. Achieved under mild reaction conditions at room temperature, the metal-free synthetic protocol was shown to be applicable to primary, secondary and tertiary NHPIs to
    描述了一种在蓝色 LED(发光二极管)光(456 nm)下通过N- (酰氧基)邻苯二甲酰亚胺酯(NHPI)对喹啉、异喹啉和吡啶进行 Hantzsch 酯介导的 Minisci 型 C2 烷基化的合成方法。在室温下温和的反应条件下,无金属合成方案被证明适用于一级、二级和三级 NHPI,以得到烷基化N-杂环产物的产率为 21–99%。在引入手性磷酸后,还实现了反应的不对称形式,并提供了 53-99% 的产物对映体过量 (ee) 值。反应机制被描述为涉及电子供体受体 (EDA) 复合物的激发,该复合物由 Hantzsch 酯和 NHPI 之间的弱静电相互作用形成,其产生氧化还原活性酯的假定自由基物质,该自由基物质经历加成到N-杂环.
  • Acylase I catalysed hydrolysis of para-substituted(S)-phenylalanine derivatives from mixtures of the racemic ortho- and para-substituted isomers
    作者:Christopher J. Easton、Jason B. Harper
    DOI:10.1016/s0040-4039(98)00997-6
    日期:1998.7
    para-Substituted(S)-phenylalanines may be obtained by treatment of the corresponding mixtures of ortho- and para-substitutedN-acetyl-(RS)-phenylalanines with Acylase I from porcine kidney. The selectivity of the enzyme may be attributed to its evolution to digest peptide derivatives of (S)-phenylalanine and (S)-tyrosine.
    对位取代的(S)-苯丙氨酸可以通过用猪肾脏中的酰基转移酶I处理邻位和对位取代的N-乙酰基-(RS)-苯丙氨酸的相应混合物来获得。该酶的选择性可归因于其消化(S)-苯丙氨酸和(S)-酪氨酸的肽衍生物的进化。
  • [EN] INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES<br/>[FR] INHIBITEURS DE PROTÉINES TYROSINE PHOSPHATASES
    申请人:UNIV INDIANA RES & TECH CORP
    公开号:WO2014055768A1
    公开(公告)日:2014-04-10
    Novel protein tyrosine phosphatase (PTP) inhibitor compounds synthesized from phosphonodifluoromethyl phenylalanine (F2Pmp) are provided. Use of these compounds for inhibiting a PTP enzyme (such as PTP-MEG2), as well as treating a disease, disorder, or condition associated with inappropriate activity of a PTP (such as type 2 diabetes), is also provided.
    提供了从磷酸二氟甲基苯丙氨酸(F2Pmp)合成的新型蛋白酪氨酸磷酸酶(PTP)抑制剂化合物。还提供了使用这些化合物来抑制PTP酶(如PTP-MEG2),以及治疗与PTP不当活性相关的疾病、紊乱或病况(如2型糖尿病)的方法。
  • [EN] pH-SENSITIVE PEPTIDES<br/>[FR] PEPTIDES SENSIBLES AU PH
    申请人:RHODE ISLAND COUNCIL ON POSTSECONDARY EDUCATION
    公开号:WO2017165452A1
    公开(公告)日:2017-09-28
    The present subject matter provides pH triggered peptides, as well as compositions methods, devices, and systems comprising the same. The pH triggered peptides include cyclic and short linear peptides, and may have higher affinity to a membrane lipid bilayer at low pH than at neutral or high pH.
    本主题提供了pH触发的肽以及包含它们的组合物、方法、装置和系统。pH触发的肽包括环状和短线性肽,可能在低pH下与膜脂双层具有比中性或高pH下更高的亲和力。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物